BRELOVITUG
UNII 4M5NX28KQZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Brelovitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4M5NX28KQZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3033337-14-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4M5NX28KQZ
CAS Registry Number
3033337-14-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BRELOVITUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224719
National Cancer Institute reference terminology for clinical and research data.
INN ID
13576
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brelovitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRELOVITUG

Common Names & Synonyms

BRELOVITUG [INN]
IMMUNOGLOBULIN G1, ANTI-(HEPATITIS B VIRUS SURFACE ANTIGEN) (HUMAN MONOCLONAL BJT-778 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BJT-778 .LAMBDA.-CHAIN, DIMER

Technical Codes

BJT778
BJT-778

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus